Cure3 calls for artists to create an original piece of work in a Perspex cube – all in the name of Parkinson’s research. We find out more about the focus of this year’s fundraising exhibition
The third edition of the Cure3 exhibition, which raises money for UK charity Cure Parkinson’s Trust, brings together original artwork from 80 renowned international artists – and, in a special addition to this year’s event, creations from 11 fashion designers.
This year’s line-up sees top designers including Roksanda Ilinčić, Giles Deacon and Monika Dugar joining artists likeConrad Shawcross, Ron Arad, Rana Begum, Annie Morris and Idris Khan, in raising funding for Parkinson’s research.
The selling exhibition, which will take place from 5-8 September this year, challenges artists to create a new piece of artwork in a bespoke Perspex cube, which measures just 20cm3. This format is inspired by the ‘boxed in’ feeling of the condition, described by Cure Parkinson’s Trust founder, Tom Isaacs.
Since its launch in 2017, the project has raised more than £750,000. The Cure3 team hope to reach £1m of fundraising through artwork sales, alongside profits from a specially designed scarf created by heritage brand, Richard Allan London.
“It is about representing the hope that one-day we will be able to find a cure”
Some of the Cure3 artists cite a personal connection to the condition as a reason for taking part in the exhibition.
Award-winning designer Giles Deacon says: “I mainly work with charities that have a personal resonance and due to the fact that I have three close friends with Parkinson’s, it gives the initiative added meaning.”
Designer Giles Deacon, with his Cure3 cube.
Bouke de Vries, who specialises in ceramics and porcelain, says his partner’s Parkinson’s motivated him to take part: “Anything I can do to work towards a cure is my duty.”
Artist Mali Morris, who has designed a cube containing a colourful concertina of paper, created her piece in memory of her father, sister-in-law, and friend John McLean, who all had Parkinson’s.
Artist Mali Morris, with her design.
Other artists have created pieces inspired by the condition itself. “I began thinking about the cube and that I might make a coloured box of wool,” says contemporary artist and sculptor, Andy Goldsworthy. “I just grabbed a lump of fleece and rammed it into the box not really knowing what to expect. The transformation was extraordinary. It was like looking into another world. Afterwards I remembered that the farmer who owns the sheep around my home has Parkinson’s.”
Fashion designer Roksanda Ilinčić, took a different approach, working with textiles to reflect her thoughts on the future of Parkinson’s treatment.
“Using the specially designed print, the fabric has been moulded into the abstract shape of a brain to signify a perfectly functioning mind with all the creative thoughts and ideas represented through the contrasting colours and patterns. It is about representing the hope that one day we will be able to find a cure for Parkinson’s.”
Find out more about Cure3
For a limited time before the exhibition, some of the Cure3 artwork will be on display in the windows of London department store Fenwick. Cubes created for the exhibition will be available to buy on its website from 8am, 8 September and will also be displayed at Bonhams, an auction house in London, UK.
Parkinson’s UK urges British government to change stance on disability assessments
Parkinson’s UK urges government to change disability allowance
7 days ago
Is there a link between Parkinson’s disease and blood vessel dysfunction?
Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.
New swab test may help with Parkinson’s disease diagnosis
Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…
Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?
A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.